ARATANA THERAPEUTICS, INC.

Profile

Company Names

ARATANA THERAPEUTICS, INC.

Addresses

1901 OLATHE BOULEVARD, KANSAS CITY, KS 66103

Phone Numbers

(913) 951-2130

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$39,750,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-10-15 
$29,750,000.00 
$29,750,000.00 
$0.00 
Equity 
3
2012-12-17 
$0.00 
$12,000,000.00 
$12,000,000.00 
Equity 
2
2011-09-12 
$0.00 
$15,500,000.00 
$15,500,000.00 
Equity 
1
2010-12-27 
$10,000,000.00 
$20,000,000.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RIP 
 
GERBER 
DIRECTOR
ARATANA THERAPEUTICS, INC.
ROBERT 
 
GERBER 
DIRECTOR
LOC-AID TECHNOLOGIES INC   |  LOC-AID TECHNOLOGIES, INC.   |  ERIE ACQUISITION HOLDINGS, INC.   |  ARATANA THERAPEUTICS, INC.   |  TECHNOCOM CORP
ERNST 
 
HEINEN, D.V.M., PH.D. 
EXECUTIVE OFFICER
ARATANA THERAPEUTICS, INC.
JAY 
 
LICHTER 
EXECUTIVE OFFICER, DIRECTOR
ARATANA THERAPEUTICS, INC.   |  OTONOMY, INC.   |  SYNTHORX, INC.   |  ARISTAMD, INC.   |  CARBON ROBOTICS INC.   |  CELLULAR APPROACHES, INC.   |  AVALON BIOVENTURES SPV I, L.P.   |  ENLAZA THERAPEUTICS, INC.   |  AVALON BIOVENTURES SPV II, L.P.
JAY 
 
LICHTER, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
REVISION THERAPEUTICS, INC.   |  OTONOMY, INC.   |  ARATANA THERAPEUTICS, INC.   |  JANUX THERAPEUTICS, INC.   |  NERIO THERAPEUTICS, INC.   |  ARIALYS THERAPEUTICS, INC.
LOUISE 
A. 
MAWHINNEY 
EXECUTIVE OFFICER
IKONISYS INC   |  ARATANA THERAPEUTICS, INC.
RON 
 
MEEUSEN 
DIRECTOR
ALLYLIX INC.   |  ARATANA THERAPEUTICS, INC.   |  ENEVOLV, INC.   |  VESTARON CORP   |  AGRIVIDA INC   |  ASILOMAR BIO, INC.   |  CULTIVIAN SANDBOX FOOD + AGRICULTURE FUND III, LP   |  SOUND AGRICULTURE CO
RONALD L. 
 
MEEUSEN 
DIRECTOR
ARATANA THERAPEUTICS, INC.
RONALD 
L. 
MEEUSEN, PH.D. 
DIRECTOR
ARATANA THERAPEUTICS, INC.
LINDA 
 
RHODES 
EXECUTIVE OFFICER, DIRECTOR
ARATANA THERAPEUTICS, INC.   |  IMMUCELL CORP /DE/   |  CELLULAR LONGEVITY, INC.
LINDA 
 
RHODES, V.M.D., PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ARATANA THERAPEUTICS, INC.
DAVID 
 
ROSEN 
EXECUTIVE OFFICER
ARATANA THERAPEUTICS, INC.   |  H.O.P. ENTERTAINMENT, LLC   |  ABLATIVE SOLUTIONS, INC.   |  NEURALIEVE, LLC   |  ENEURA THERAPEUTICS LLC   |  HELIKON CYCLES LLC   |  WAVESEER, LLC   |  ENEURA, INC.   |  WAVESEER OF LAS VEGAS, LLC   |  WAVESEER OF ILLINOIS, LLC   |  WAVESEER OF OREGON, LLC   |  PARNELL PHARMACEUTICALS HOLDINGS LTD   |  RUBRIC CAPITAL PARTNERS LP   |  JENNY-S OF ILLINOIS I, LLC   |  AMPLIFICA HOLDINGS GROUP, INC.   |  ARUENE CORP   |  RUBRIC BSR FUND LLC   |  BLACKSTONE REAL ESTATE DEBT STRATEGIES V (LUX) SCSP   |  BLACKSTONE REAL ESTATE DEBT STRATEGIES V (FEEDER FUND) (LUX) SCSP   |  BLACKSTONE REAL ESTATE DEBT STRATEGIES V L.P.   |  BLACKSTONE REAL ESTATE DEBT STRATEGIES V (FEEDER FUND) L.P.   |  RUBRIC LONG TERM OPPORTUNITIES ONSHORE FUND LP   |  RUBRIC LONG TERM OPPORTUNITIES OFFSHORE FUND LP   |  VELO-1, INC.
STEVEN 
 
ST. PETER 
EXECUTIVE OFFICER, DIRECTOR
PHARMATHENE, INC   |  XANODYNE PHARMACEUTICALS INC   |  MPM BIOVENTURES V, L.P.   |  RHYTHM PHARMACEUTICALS, INC.   |  ARATANA THERAPEUTICS, INC.   |  PROTEON THERAPEUTICS INC
STEVEN 
 
ST. PETER, M.D. 
EXECUTIVE OFFICER, DIRECTOR
SYNDAX PHARMACEUTICALS INC   |  ARATANA THERAPEUTICS, INC.
JULIA 
A. 
STEPHANUS 
EXECUTIVE OFFICER
ARATANA THERAPEUTICS, INC.
CRAIG 
 
TOOMAN 
DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  ARATANA THERAPEUTICS, INC.   |  INSITE VISION INC   |  SILENCE THERAPEUTICS PLC
JOHN 
 
VANDER VORT 
DIRECTOR
ARATANA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-10-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-10-15 
2012-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-17 
2011-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-12 
2011-01-07
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-12-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#